Long Road Investment Counsel LLC Lowers Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Long Road Investment Counsel LLC lowered its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 7.6% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 44,050 shares of the pharmacy operator’s stock after selling 3,600 shares during the quarter. Long Road Investment Counsel LLC’s holdings in Walgreens Boots Alliance were worth $411,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the business. First Financial Corp IN raised its stake in shares of Walgreens Boots Alliance by 49.2% during the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after acquiring an additional 885 shares in the last quarter. Golden State Wealth Management LLC purchased a new stake in shares of Walgreens Boots Alliance in the 4th quarter valued at $26,000. Riverview Trust Co boosted its holdings in shares of Walgreens Boots Alliance by 123.8% in the 4th quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator’s stock valued at $27,000 after acquiring an additional 1,590 shares during the last quarter. Venturi Wealth Management LLC purchased a new stake in Walgreens Boots Alliance during the fourth quarter worth $28,000. Finally, TD Private Client Wealth LLC boosted its holdings in Walgreens Boots Alliance by 8,670.3% during the third quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock worth $29,000 after buying an additional 3,208 shares in the last quarter. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Up 0.3 %

Shares of Walgreens Boots Alliance stock opened at $11.26 on Tuesday. Walgreens Boots Alliance, Inc. has a 52-week low of $8.08 and a 52-week high of $22.05. The company has a 50 day moving average of $10.86 and a 200 day moving average of $9.77. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. The company has a market capitalization of $9.73 billion, a P/E ratio of -1.10, a P/E/G ratio of 1.31 and a beta of 0.62.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, topping analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The company had revenue of $39.50 billion for the quarter, compared to analysts’ expectations of $37.40 billion. During the same quarter last year, the company earned $0.66 earnings per share. The firm’s revenue for the quarter was up 7.6% on a year-over-year basis. As a group, research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of analysts recently issued reports on WBA shares. Bank of America increased their price target on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a report on Monday, January 13th. Wolfe Research upgraded shares of Walgreens Boots Alliance to a “hold” rating in a research report on Monday, February 24th. StockNews.com initiated coverage on shares of Walgreens Boots Alliance in a research report on Tuesday. They set a “hold” rating for the company. Royal Bank of Canada raised their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a research report on Wednesday, January 15th. Finally, Evercore ISI increased their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research note on Monday, January 13th. Four analysts have rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $11.54.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.